Catalyst Wire Dossier Catalyst Wire Dossier

anagliptin

anagliptin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anagliptin, covering 2019-08-28 to 2019-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial [Phase 4]

See pricing